A controlled, longitudinal study of dementia in Parkinson's disease
- PMID: 1640232
- PMCID: PMC489167
- DOI: 10.1136/jnnp.55.7.566
A controlled, longitudinal study of dementia in Parkinson's disease
Abstract
Serial assessments of cognition, mood, and disability were carried out at nine month intervals over a 54 month period on a cohort of 87 patients with Parkinson's disease (PD) and a matched cohort of 50 control subjects. Dementia was diagnosed from data by rigorously applying DSM-III-R criteria. Initially, 6% (5/87) PD patients were demented, compared with none of the 50 control subjects. A further 10 PD patients met the dementia criteria during the follow up period; this was equivalent, with survival analysis, to a cumulative incidence of 19%. With the number of person years of observation as the denominator, the incidence was 47.6/1000 person years of observation. None of the control subjects fulfilled dementia criteria during the follow up period. The patients with PD who became demented during follow up were older at onset of Parkinson's disease than patients who did not become demented, had a longer duration of Parkinson's disease, and were older at inclusion to the study.
Similar articles
-
Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom.Mov Disord. 2004 Sep;19(9):1043-9. doi: 10.1002/mds.20216. Mov Disord. 2004. PMID: 15372593
-
A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease.Neurology. 2000 Apr 25;54(8):1596-602. doi: 10.1212/wnl.54.8.1596. Neurology. 2000. PMID: 10762499
-
A controlled study of dementia in Parkinson's disease over 54 months.Adv Neurol. 1993;60:470-4. Adv Neurol. 1993. PMID: 8420172 No abstract available.
-
Parkinson's disease: epidemiology, (differential) diagnosis, therapy, relation to dementia.Arzneimittelforschung. 1995 Mar;45(3A):386-9. Arzneimittelforschung. 1995. PMID: 7763330 Review.
-
Sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure.J Neural Transm (Vienna). 2010 Mar;117(3):353-67. doi: 10.1007/s00702-010-0370-2. Epub 2010 Jan 30. J Neural Transm (Vienna). 2010. PMID: 20119649 Review.
Cited by
-
Neurocognitive and atrophic patterns in Parkinson's disease based on subjective memory complaints.J Neurol. 2012 Aug;259(8):1706-12. doi: 10.1007/s00415-011-6404-3. J Neurol. 2012. PMID: 22289965
-
Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for "mild cognitive impairment" and biomarkers.Neuropsychol Rev. 2008 Mar;18(1):103-19. doi: 10.1007/s11065-008-9055-0. Epub 2008 Mar 6. Neuropsychol Rev. 2008. PMID: 18322801 Review.
-
Population Base Rates and Disease Course of Common Psychiatric and Neurodegenerative Disorders.Neuropsychol Rev. 2017 Sep;27(3):284-301. doi: 10.1007/s11065-017-9357-1. Epub 2017 Sep 22. Neuropsychol Rev. 2017. PMID: 28939959 Review.
-
Genetic testing and Parkinson disease: assessment of patient knowledge, attitudes, and interest.J Genet Couns. 2011 Aug;20(4):384-95. doi: 10.1007/s10897-011-9362-0. Epub 2011 Apr 8. J Genet Couns. 2011. PMID: 21476119 Free PMC article.
-
Association between presenting motor symptoms and the risk of cognitive impairment in Parkinson's disease.J Neurol Neurosurg Psychiatry. 1994 Oct;57(10):1203-7. doi: 10.1136/jnnp.57.10.1203. J Neurol Neurosurg Psychiatry. 1994. PMID: 7931381 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous